Related Experiment Video
Updated: Feb 10, 2026

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
The Impact of Nirsevimab on Bronchiolitis-Related Hospitalizations: A Multicenter Italian Retrospective Comparative
Sergio Ghirardo1,2, Barbara Madini3, Nicola Ullmann4
1Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Insights
Nirsevimab significantly reduced respiratory syncytial virus (RSV) hospitalizations for bronchiolitis in Italian infants by 48%. The immunoprophylaxis reshaped viral patterns, highlighting its public health benefit.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Bronchiolitis is a major cause of infant hospitalization globally.
- Respiratory syncytial virus (RSV) is the primary driver of bronchiolitis.
Purpose of the Study:
- To evaluate the impact of nirsevimab immunoprophylaxis on RSV-related bronchiolitis hospitalizations in Italy.
- To assess changes in viral epidemiology during the 2024-2025 winter season.
Main Methods:
- Multicenter retrospective comparative study.
- Analysis of bronchiolitis admissions across nine Italian hospitals.
- Comparison of hospitalization data from the 2024-2025 season with the previous season.
Main Results:
- A 48% decrease in bronchiolitis admissions was observed.
- RSV positivity was significantly lower in nirsevimab-immunized infants (48%) compared to non-immunized (73%).
- Fewer RSV-related coinfections and a lower intubation rate (<0.5%) were noted.
Conclusions:
- Nirsevimab effectively reduces RSV-associated hospitalizations and alters the viral landscape of bronchiolitis.
- A shift in pathogen prevalence, with decreased RSV and increased rhinovirus/enterovirus, was observed.
- Widespread implementation of nirsevimab immunoprophylaxis is recommended for public health benefits.
Introduction:
Bronchiolitis is the leading cause of infant hospitalizations worldwide, primarily driven by respiratory syncytial virus (RSV).
Methods:
This multicenter retrospective comparative study assessed the impact of immunoprophylaxis with nirsevimab against RSV on bronchiolitis-related hospitalizations in Italy during the 2024-2025 winter season.
Results:
Data from nine Italian hospitals showed a substantial 48% decrease in bronchiolitis admissions compared to the previous season (438 vs. 832 admissions). Among hospitalized infants, only 23% had received immunoprophylaxis. RSV positivity dropped significantly among immunized patients (48%) versus non-immunized (73%, p < 0.0001), with fewer RSV-related coinfections.
Discussion:
While indicators of illness severity-such as ICU admission, respiratory support needs, and complications-were generally lower, no statistically significant differences in disease course were observed between immunized and non-immunized hospitalized infants. A shift in viral epidemiology was noted, with a reduction in RSV dominance and increased detection of rhinovirus and enterovirus, suggesting a pathogen replacement effect. The 2024-2025 season also saw a lower intubation rate (< 0.5%), pointing to an overall milder disease course.
Conclusions:
This study supports the effectiveness of nirsevimab in reducing RSV-associated hospitalizations and reshaping the virological landscape of bronchiolitis in Italy. Early and widespread implementation of immunoprophylaxis is recommended to maximize public health benefits.
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
Impact of Groups on Groups
Impact
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Comparative Excretory Systems

